Chromcore Lifesciences Llp Profile
Key Indicators
- Obligation of Contribution ₹ 3.69 Cr
- Company Age 9 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 Cr
- Satisfied Charges ₹ 5.50 Cr
About Chromcore Lifesciences Llp
Chromcore Lifesciences Llp (CLL) is 9 Year, 2 Months old Limited Liability Partnership 16 November 2015. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 3.69 Cr as per MCA.
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN/FCRN
AAF-1665
- Incorporation Date
16 Nov 2015
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Vijayawada
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Chromcore Lifesciences Llp?
Designated Partners (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kiran Edupuganti  | Designated Partner | 16-Nov-2015 | Current |
| Rajiv Popat | Designated Partner | 09-Nov-2020 | Current |
| Uppalapati Rajakumar | Designated Partner | 20-May-2022 | Current |
Financial Performance of Chromcore Lifesciences Llp.
Enhance accessibility to Chromcore Lifesciences Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chromcore Lifesciences Llp?
Unlock access to Chromcore Lifesciences Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Apex Chromatography Private LimitedRajiv Popat is a mutual person
Recronex Labtech LlpRajiv Popat is a mutual person
- Apex Inhalation Llp
Rajiv Popat is a mutual person
Charges (Loans)
₹1.20 Cr
₹5.50 Cr
Charges Breakdown by Lending Institutions
- Union Bank Of India : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Dec 2021 | Union Bank Of India | ₹1.20 Cr | Open |
| 23 Jan 2020 | Union Bank Of India | ₹5.50 Cr | Satisfied |
How Many Employees Work at Chromcore Lifesciences Llp?
Unlock and access historical data on people associated with Chromcore Lifesciences Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chromcore Lifesciences Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chromcore Lifesciences Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
